Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

TCL1 Expression in Chronic Lymphocytic Leukemia Correlates with the Intensity of 11q Deletions and ZAP-70.

Laura Rassenti, PhD, L. Huynh, B.S., G.W. Basak, MD, PhD, E.M. Ghia, PhD, D. Van Dyke, PhD, N. Heerema, PhD, D. Zahrieh, PhD, P. DalCin, PhD, M.L. Dell’Aquila, PhD, P. Koduru, PhD, J.C. Byrd, MD, N.E. Kay, MD, K.R. Rai, MD, J.R. Brown, MD, PhD, W.W. Wierda, MD, PhD, A.W. Greaves, B.S., Thomas J. Kipps, MD, PhD

Blood (2007) 110 (11): 2068.

https://doi.org/10.1182/blood.V110.11.2068.2068

Published: 2007

Journal Articles

A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.

Rebecca B. Klisovic, W. Blum, X. Wei, S. Liu, C. Kefauver, L. Huynh, J. A. Zwiebel, J. C. Byrd, M. R. Grever, G. Marcucci

Blood (2005) 106 (11): 2790.

https://doi.org/10.1182/blood.V106.11.2790.2790

Published: 2005

Journal Articles

Intracellular Levels of Oblimersen Sodium and Target Downregulation Correlates to Clinical Activity of bcl-2 Antisense in Acute Myeoid Leukemia (AML).

Guido Marcucci, W. Stock, G. Dai, S. Liu, R. Klisovic, M. I. Klisovic, D. Sher, L. Huynh, S. Frankel, W. Blum, R. A. Larson, M. R. Grever, J. C. Byrd, K. K. Chan

Blood (2004) 104 (11): 1170.

https://doi.org/10.1182/blood.V104.11.1170.1170

Published: 2004

Journal Articles

Promotes Gene Expression by Disrupting the DNA Binding of the AML1/ETO and HDAC1 Repressor Complex.

Shujun Liu, M. I. Klisovic, T. Shen, J. Yu, G. Dai, L. Huynh, T. Vukosavljevic, S. Whitman, D. Perrotti, G. Marcucci

Blood (2004) 104 (11): 4386.

https://doi.org/10.1182/blood.V104.11.4386.4386

Published: 2004

Journal Articles

Enhancement of hemopoietic recovery after bone marrow transplantation with the addition of nucleated blood cells in mice

AR Zander, DS Verma, G Spitzer, L Huynh, D Johnston, M Beran, KA Dicke

Blood (1980) 56 (6): 1132–1135.

https://doi.org/10.1182/blood.V56.6.1132.1132

Published: 1980

NARROW

TCL1 Expression in Chronic Lymphocytic Leukemia Correlates with the Intensity of 11q Deletions and ZAP-70.

A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.

Intracellular Levels of Oblimersen Sodium and Target Downregulation Correlates to Clinical Activity of bcl-2 Antisense in Acute Myeoid Leukemia (AML).

Promotes Gene Expression by Disrupting the DNA Binding of the AML1/ETO and HDAC1 Repressor Complex.

Enhancement of hemopoietic recovery after bone marrow transplantation with the addition of nucleated blood cells in mice

Email alerts

ASH Publications

American Society of Hematology

TCL1 Expression in Chronic Lymphocytic Leukemia Correlates with the Intensity of 11q Deletions and ZAP-70.

A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.

Intracellular Levels of Oblimersen Sodium and Target Downregulation Correlates to Clinical Activity of bcl-2 Antisense in Acute Myeoid Leukemia (AML).

Promotes Gene Expression by Disrupting the DNA Binding of the AML1/ETO and HDAC1 Repressor Complex.

Enhancement of hemopoietic recovery after bone marrow transplantation with the addition of nucleated blood cells in mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only